These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 17638203)

  • 1. HIV type 1 superinfection with a dual-tropic virus and rapid progression to AIDS: a case report.
    Gottlieb GS; Nickle DC; Jensen MA; Wong KG; Kaslow RA; Shepherd JC; Margolick JB; Mullins JI
    Clin Infect Dis; 2007 Aug; 45(4):501-9. PubMed ID: 17638203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The probable source of both the primary multidrug-resistant (MDR) HIV-1 strain found in a patient with rapid progression to AIDS and a second recombinant MDR strain found in a chronically HIV-1-infected patient.
    Blick G; Kagan RM; Coakley E; Petropoulos C; Maroldo L; Greiger-Zanlungo P; Gretz S; Garton T
    J Infect Dis; 2007 May; 195(9):1250-9. PubMed ID: 17396993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual HIV-1 infection associated with rapid disease progression.
    Gottlieb GS; Nickle DC; Jensen MA; Wong KG; Grobler J; Li F; Liu SL; Rademeyer C; Learn GH; Karim SS; Williamson C; Corey L; Margolick JB; Mullins JI
    Lancet; 2004 Feb; 363(9409):619-22. PubMed ID: 14987889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemokine (C-C motif) receptor 5-using envelopes predominate in dual/mixed-tropic HIV from the plasma of drug-naive individuals.
    Irlbeck DM; Amrine-Madsen H; Kitrinos KM; Labranche CC; Demarest JF
    AIDS; 2008 Jul; 22(12):1425-31. PubMed ID: 18614865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV type 1 chemokine coreceptor use among antiretroviral-experienced patients screened for a clinical trial of a CCR5 inhibitor: AIDS Clinical Trial Group A5211.
    Wilkin TJ; Su Z; Kuritzkes DR; Hughes M; Flexner C; Gross R; Coakley E; Greaves W; Godfrey C; Skolnik PR; Timpone J; Rodriguez B; Gulick RM
    Clin Infect Dis; 2007 Feb; 44(4):591-5. PubMed ID: 17243065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of HIV tropism on decreases in CD4 cell count, clinical progression, and subsequent response to a first antiretroviral therapy regimen.
    Waters L; Mandalia S; Randell P; Wildfire A; Gazzard B; Moyle G
    Clin Infect Dis; 2008 May; 46(10):1617-23. PubMed ID: 18419499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absence of HIV-1 superinfection 1 year after infection between 1985 and 1997 coincides with a reduction in sexual risk behavior in the seroincident Amsterdam cohort of homosexual men.
    Rachinger A; Stolte IG; van de Ven TD; Burger JA; Prins M; Schuitemaker H; van 't Wout AB
    Clin Infect Dis; 2010 May; 50(9):1309-15. PubMed ID: 20367230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV-1 dual infection is associated with faster CD4+ T-cell decline in a cohort of men with primary HIV infection.
    Cornelissen M; Pasternak AO; Grijsen ML; Zorgdrager F; Bakker M; Blom P; Prins JM; Jurriaans S; van der Kuyl AC
    Clin Infect Dis; 2012 Feb; 54(4):539-47. PubMed ID: 22157174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid clearance of virus after acute HIV-1 infection: correlates of risk of AIDS.
    Blattner WA; Oursler KA; Cleghorn F; Charurat M; Sill A; Bartholomew C; Jack N; O'Brien T; Edwards J; Tomaras G; Weinhold K; Greenberg M
    J Infect Dis; 2004 May; 189(10):1793-801. PubMed ID: 15122515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular biological assessment methods and understanding the course of the HIV infection.
    Katzenstein TL
    APMIS Suppl; 2003; (114):1-37. PubMed ID: 14626050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In-depth analysis of a heterosexually acquired human immunodeficiency virus type 1 superinfection: evolution, temporal fluctuation, and intercompartment dynamics from the seronegative window period through 30 months postinfection.
    McCutchan FE; Hoelscher M; Tovanabutra S; Piyasirisilp S; Sanders-Buell E; Ramos G; Jagodzinski L; Polonis V; Maboko L; Mmbando D; Hoffmann O; Riedner G; von Sonnenburg F; Robb M; Birx DL
    J Virol; 2005 Sep; 79(18):11693-704. PubMed ID: 16140747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coinfection and superinfection in patients with long-term, nonprogressive HIV-1 disease.
    Casado C; Pernas M; Alvaro T; Sandonis V; García S; Rodríguez C; del Romero J; Grau E; Ruiz L; Lopez-Galindez C
    J Infect Dis; 2007 Sep; 196(6):895-9. PubMed ID: 17703421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology and predictive factors for chemokine receptor use in HIV-1 infection.
    Moyle GJ; Wildfire A; Mandalia S; Mayer H; Goodrich J; Whitcomb J; Gazzard BG
    J Infect Dis; 2005 Mar; 191(6):866-72. PubMed ID: 15717260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absence of coreceptor switch with disease progression in human immunodeficiency virus infections in India.
    Cecilia D; Kulkarni SS; Tripathy SP; Gangakhedkar RR; Paranjape RS; Gadkari DA
    Virology; 2000 Jun; 271(2):253-8. PubMed ID: 10860879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in molecular evolution between switch (R5 to R5X4/X4-tropic) and non-switch (R5-tropic only) HIV-1 populations during infection.
    Mild M; Kvist A; Esbjörnsson J; Karlsson I; Fenyö EM; Medstrand P
    Infect Genet Evol; 2010 Apr; 10(3):356-64. PubMed ID: 19446658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Natural history of human immunodeficiency virus infection in a cohort of Chilean patients].
    Vial PA; Ferreccio C; Abarca K; Ortiz E; Noriega M; Pérez C; Labarca J; Torres M; Ferrés M; González C; Acuña G
    Rev Med Chil; 1996 May; 124(5):525-35. PubMed ID: 9035503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infection with multidrug resistant, dual-tropic HIV-1 and rapid progression to AIDS: a case report.
    Markowitz M; Mohri H; Mehandru S; Shet A; Berry L; Kalyanaraman R; Kim A; Chung C; Jean-Pierre P; Horowitz A; La Mar M; Wrin T; Parkin N; Poles M; Petropoulos C; Mullen M; Boden D; Ho DD
    Lancet; 2005 Mar 19-25; 365(9464):1031-8. PubMed ID: 15781098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV controllers suppress viral replication and evolution and prevent disease progression following intersubtype HIV-1 superinfection.
    de Azevedo SSD; Delatorre E; Côrtes FH; Hoagland B; Grinsztejn B; Veloso VG; Souza TML; Morgado MG; Bello G
    AIDS; 2019 Mar; 33(3):399-410. PubMed ID: 30531316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of human immunodeficiency virus Type 1 (HIV-1) subtype on disease progression in persons from Rakai, Uganda, with incident HIV-1 infection.
    Kiwanuka N; Laeyendecker O; Robb M; Kigozi G; Arroyo M; McCutchan F; Eller LA; Eller M; Makumbi F; Birx D; Wabwire-Mangen F; Serwadda D; Sewankambo NK; Quinn TC; Wawer M; Gray R
    J Infect Dis; 2008 Mar; 197(5):707-13. PubMed ID: 18266607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different rates of disease progression of HIV type 1 infection in Tanzania based on infecting subtype.
    Vasan A; Renjifo B; Hertzmark E; Chaplin B; Msamanga G; Essex M; Fawzi W; Hunter D
    Clin Infect Dis; 2006 Mar; 42(6):843-52. PubMed ID: 16477563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.